These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1521 related items for PubMed ID: 17919547
1. A retrospective evaluation of the use of gabapentin and pregabalin in patients with postherpetic neuralgia in usual-care settings. Gore M, Sadosky A, Tai KS, Stacey B. Clin Ther; 2007 Aug; 29(8):1655-70. PubMed ID: 17919547 [Abstract] [Full Text] [Related]
2. Comparing healthcare costs of Medicaid patients with postherpetic neuralgia (PHN) treated with lidocaine patch 5% versus gabapentin or pregabalin. Kirson NY, Ivanova JI, Birnbaum HG, Wei R, Kantor E, Puenpatom RA, Ben-Joseph RH, Summers KH. J Med Econ; 2010 Aug; 13(3):482-91. PubMed ID: 20684669 [Abstract] [Full Text] [Related]
3. Clinical characteristics, pharmacotherapy and healthcare resource use among patients with fibromyalgia newly prescribed gabapentin or pregabalin. Gore M, Sadosky AB, Zlateva G, Clauw DJ. Pain Pract; 2009 Aug; 9(5):363-74. PubMed ID: 19500273 [Abstract] [Full Text] [Related]
4. Clinical characteristics, pharmacotherapy, and healthcare resource use among patients with diabetic neuropathy newly prescribed pregabalin or gabapentin. Gore M, Tai KS, Zlateva G, Bala Chandran A, Leslie D. Pain Pract; 2011 Aug; 11(6):528-39. PubMed ID: 21435162 [Abstract] [Full Text] [Related]
5. Replacement of gabapentin with pregabalin in postherpetic neuralgia therapy. Ifuku M, Iseki M, Hidaka I, Morita Y, Komatus S, Inada E. Pain Med; 2011 Jul; 12(7):1112-6. PubMed ID: 21692969 [Abstract] [Full Text] [Related]
6. Review of current guidelines on the care of postherpetic neuralgia. Argoff CE. Postgrad Med; 2011 Sep; 123(5):134-42. PubMed ID: 21904096 [Abstract] [Full Text] [Related]
7. Pregabalin and gabapentin in matched patients with peripheral neuropathic pain in routine medical practice in a primary care setting: Findings from a cost-consequences analysis in a nested case-control study. Pérez C, Navarro A, Saldaña MT, Masramón X, Rejas J. Clin Ther; 2010 Jul; 32(7):1357-70. PubMed ID: 20678683 [Abstract] [Full Text] [Related]
8. Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective. Tarride JE, Gordon A, Vera-Llonch M, Dukes E, Rousseau C. Clin Ther; 2006 Nov; 28(11):1922-34. PubMed ID: 17213013 [Abstract] [Full Text] [Related]
9. Efficacy of gabapentin enacarbil vs placebo in patients with postherpetic neuralgia and a pharmacokinetic comparison with oral gabapentin. Backonja MM, Canafax DM, Cundy KC. Pain Med; 2011 Jul; 12(7):1098-108. PubMed ID: 21627766 [Abstract] [Full Text] [Related]
15. Cost-effectiveness analysis of a lidocaine 5% medicated plaster compared with gabapentin and pregabalin for treating postherpetic neuralgia: a german perspective. Liedgens H, Hertel N, Gabriel A, Nuijten M, Dakin H, Mitchell S, Nautrup BP. Clin Drug Investig; 2008 Dec; 28(9):583-601. PubMed ID: 18666805 [Abstract] [Full Text] [Related]
18. Initial use of pregabalin, patterns of pain-related pharmacotherapy, and healthcare resource use among older patients with fibromyalgia. Gore M, Sadosky A, Zlateva G, Clauw D. Am J Manag Care; 2010 May; 16(5 Suppl):S144-53. PubMed ID: 20586523 [Abstract] [Full Text] [Related]